Anant Labs

Zasocitinib

CAS 2272904-53-5

Overview

Zasocitinib (formerly TAK-279) is an oral, highly selective, allosteric tyrosine kinase 2 (TYK2) inhibitor being developed by Takeda Pharmaceuticals for inflammatory conditions, including moderate-to-severe plaque psoriasis, psoriatic arthritis, and Crohn's disease

Anant Labs manufacture and furnish high quality Zasocitinib impurities for global markets. Our Zasocitinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Active Pharmaceutical Ingredient